Prognostic Relevance of Type 2 Diabetes and Metformin Treatment in Head and Neck Melanoma: Results from a Population-Based Cohort Study

Prognostic Relevance of Type 2 Diabetes and Metformin Treatment in Head and Neck Melanoma: Results from a Population-Based Cohort Study

Background: Type 2 Diabetes (DM2) and the consecutively daily use of antidiabetic medication are characterized by a frequent prevalence worldwide and were shown to impact the initiation and progression of malignant diseases. While these effects were observed in a variety of malignancies, comprehensi...

Full description

Bibliographic Details
Main Authors: Steffen Spoerl, Michael Gerken, Susanne Schimnitz, Juergen Taxis, René Fischer, Sophia R. Lindner, Tobias Ettl, Nils Ludwig, Silvia Spoerl, Torsten E. Reichert, Gerrit Spanier
Format: Article
Language:English
Published: MDPI AG 2022-12-01
Series:Current Oncology
Subjects:
head and neck melanoma
type 2 diabetes
metformin
outcome
survival
recurrence
Online Access:https://www.mdpi.com/1718-7729/29/12/758

Internet

https://www.mdpi.com/1718-7729/29/12/758

Similar Items